Showing results (51-60 of 214) with videos related to
Sort By:
Pageof 22
Hormone Molecular Biology and Clinical Investigation|August 19, 2018
The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issueXiangyan Ruan, Alfred O MueckHormone Molecular Biology and Clinical Investigation|May 12, 2015
Benefits and risks during HRT: main safety issue breast cancerAlfred O Mueck, Xiangyan RuanMaturitas|August 13, 2014
Systemic progesterone therapy--oral, vaginal, injections and even transdermal?Xiangyan Ruan, Alfred O MueckBreast Care (Basel, Switzerland)|August 2, 2023
Clinical Importance of PGRMC1 in Hormone Responsive Breast CancerXiangyan Ruan, Alfred O MueckGynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 13, 2012
Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cellsXiangyan Ruan, Helen Schneck, Silke Schultz, et al.Steroids|February 22, 2011
Nomegestrol acetate, a novel progestogen for oral contraceptionAlfred O Mueck, Regine Sitruk-WareHormone Molecular Biology and Clinical Investigation|May 12, 2015
New insight on a possible mechanism of progestogens in terms of breast cancer riskHans Neubauer, Rong Chen, Helen Schneck, et al.Menopause (New York, N.Y.)|April 26, 2013
Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapyHans Neubauer, Xiangyan Ruan, Helen Schneck, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 11, 2015
Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypesYue Zhao, Xiangyan Ruan, Alfred O MueckPageof 22